Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy in the treatment of prostate cancer-Reference-Cited by-同舟云学术

Long-term outcome of a phase II trial using immunomodulatory in situ gene therapy in combination with intensity-modulated radiotherapy with or without hormonal therapy in the treatment of prostate cancer

Published:2015-12 Issue:4 Volume:4 Page:377-386
ISSN:1948-7894
Container-title:Journal of Radiation Oncology
language:en
Short-container-title:J Radiat Oncol

Author:

Teh Bin S.,Ishiyama Hiromichi,Mai Wei-Yuan,Thompson Timothy C.,Butler E. Brian

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s13566-015-0239-y.pdf

Reference39 articles.

1. Thompson TC (1999) In situ gene therapy for prostate cancer. Oncol Res 11(1):1–8

2. Hall SJ, Mutchnik SE, Chen SH, et al. (1997) Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer. Int J Cancer 70(2):183–187

3. Fujita T, Teh BS, Timme TL, et al. (2006) Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients. Int J Radiat Oncol Biol Phys 65(1):84–90

4. Satoh T, Teh BS, Timme TL, et al. (2004) Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients. Int J Radiat Oncol Biol Phys 59(2):562–571

5. Ayala G, Satoh T, Li R, et al. (2006) Biological response determinants in HSV-tk + ganciclovir gene therapy for prostate cancer. Mol Ther 13(4):716–728

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New approaches and prospects of immunotherapy and gene therapy for prostate cancer;Journal of Translational Genetics and Genomics;2024-03-29

2. Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy;Advances in Radiation Oncology;2021-07

3. The impact of γ-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use;Cancer Cell International;2017-10-24

4. Chimeric Trojan Protein Insertion in Lentiviral Membranes Makes Lentiviruses Susceptible to Neutralization by Anti-Tetanus Serum Antibodies;Human Gene Therapy;2017-03